United States

Zhejiang Hisun Pharmaceutical Co Ltd (600267.SS)

600267.SS on Shanghai Stock Exchange

9 Dec 2016
Change (% chg)

¥-0.02 (-0.15%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 600267.SS


Zhejiang Hisun Pharmaceutical Co.,Ltd. is principally engaged in the manufacture and distribution of pharmaceuticals. The Company's products include antineoplastic drugs, cardiovascular drugs, anti-infection drugs, endocrine control drugs, anthelmintic, as well as animal remedies, among others. The Company also involves in the... (more)


Beta: 1.08
Market Cap(Mil.): ¥13,015.37
Shares Outstanding(Mil.): 965.53
Dividend: 0.07
Yield (%): 0.52


  600267.SS Industry Sector
P/E (TTM): 324.27 29.73 30.40
EPS (TTM): 0.04 -- --
ROI: 1.66 15.87 15.24
ROE: 0.58 16.99 16.58

BRIEF-Zhejiang Hisun Pharmaceutical's share trade to resume on Nov 21

Further company coverage: (Reporting by Hong Kong newsroom)

Nov 18 2016

BRIEF-Zhejiang Hisun Pharmaceutical gets nod for clinic trial

* Says it gets China Food and Drug Administration's approval for three original chemical drugs' clinic trial

Nov 07 2016

BRIEF-Zhejiang Hisun Pharmaceutical to apply for comprehensive credit line of 300 mln yuan

* Says it will apply for a comprehensive credit line of up to 300 million yuan from China Merchants Bank with a term of two years

Oct 31 2016

BRIEF-Zhejiang Hisun Pharmaceutical unit gets FDA approval

* Says its unit receives ANDA approval for its irbesartan and hydrochlorothiazide tablets from U.S Food and Drug Administration

Oct 20 2016

BRIEF-Zhejiang Hisun Pharma plans share issue to fund project, repay loans

* Says it aims to raise up to 1.2 billion yuan ($179.95 million)in private placement of shares to fund project, repay bank loans

Oct 17 2016

BRIEF-Zhejiang Hisun Pharmaceutical's shares to halt trade pending private placement plan

* Says its shares to halt trading from Sept 9 pending private placement plan

Sep 08 2016

BRIEF-Zhejiang Hisun Pharma signs agreement with U.S.-based Celsion Corp

* Says it signs agreement on technology transfer, production and products supply with Celsion Corp

Aug 16 2016

BRIEF-Zhejiang Hisun Pharma plans debt financing tools, China Devt Fund to boost unit capital

* Says unit plans to issue up to 1 billion yuan ($150.63 million) debt financing instruments

Aug 15 2016

BRIEF-Zhejiang Hisun Pharmaceutical unit gets GMP certificate

July 25 Zhejiang Hisun Pharmaceutical Co., Ltd. :

Jul 24 2016

BRIEF-Zhejiang Hisun Pharmaceutical signs $3 mln technology transfer agreement with Nascent

July 19 Zhejiang Hisun Pharmaceutical Co., Ltd. :

Jul 18 2016

Earnings vs. Estimates